These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20329028)

  • 1. A theoretical examination of double-blind design.
    Preshaw RM
    Can Med Assoc J; 1967 Sep; 97(10):545. PubMed ID: 20329028
    [No Abstract]   [Full Text] [Related]  

  • 2. The Double-Blind Design: A Theoretical Re-examination.
    Hoffer A
    Can Med Assoc J; 1968 Jan; 98(3):174. PubMed ID: 20329136
    [No Abstract]   [Full Text] [Related]  

  • 3. A theoretical examination of double-blind design.
    Sprott DA
    Can Med Assoc J; 1968 Jan; 98(2):124. PubMed ID: 4864656
    [No Abstract]   [Full Text] [Related]  

  • 4. The double-blind design: a theoretical re-examination.
    Auerbach A
    Can Med Assoc J; 1967 Dec; 97(24):1480-2. PubMed ID: 6061611
    [No Abstract]   [Full Text] [Related]  

  • 5. A theoretical examination of double-blind design.
    Hoffer A
    Can Med Assoc J; 1967 Jul; 97(3):123-7. PubMed ID: 5339046
    [No Abstract]   [Full Text] [Related]  

  • 6. ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension.
    Gault LM; Lenz RA; Ritchie CW; Meier A; Othman AA; Tang Q; Berry S; Pritchett Y; Robieson WZ
    Alzheimers Res Ther; 2016 Oct; 8(1):44. PubMed ID: 27756421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discomfort during double-contrast barium enema examination: a placebo-controlled double-blind evaluation of the effect of glucagon and diazepam.
    Lappas JC; Maglinte DD; Chernish SM; Hage JP; Kelvin FM
    Radiology; 1995 Oct; 197(1):95-9. PubMed ID: 7568861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind versus deceptive administration of a placebo.
    Kirsch I; Weixel LJ
    Behav Neurosci; 1988 Apr; 102(2):319-23. PubMed ID: 3365327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ["Sham Needle"--Design and Application of A Double-blind Placebo Needle Assembly].
    Yan L; Ma LH
    Zhen Ci Yan Jiu; 2016 Feb; 41(1):85-6. PubMed ID: 27141628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydromorphone extended release for neuropathic and non-neuropathic/nociceptive chronic low back pain: a post hoc analysis of data from a randomized, multicenter, double-blind, placebo-controlled clinical trial.
    Nalamachu S; Hale M; Khan A
    J Opioid Manag; 2014; 10(5):311-22. PubMed ID: 25350473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the efficacy of atypical antipsychotics in open uncontrolled versus double-blind controlled trials in schizophrenia.
    Pajonk FG; Holzbach R; Naber D
    Psychopharmacology (Berl); 2002 Jun; 162(1):29-36. PubMed ID: 12107614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group.
    Thal LJ; Schwartz G; Sano M; Weiner M; Knopman D; Harrell L; Bodenheimer S; Rossor M; Philpot M; Schor J; Goldberg A
    Neurology; 1996 Dec; 47(6):1389-95. PubMed ID: 8960716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do open label blinded outcome studies of novel anticoagulants versus warfarin have equivalent validity to those carried out under double-blind conditions?
    O'Neil WM; Welner SA; Lip GY
    Thromb Haemost; 2013 Mar; 109(3):497-503. PubMed ID: 23348922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind randomised controlled trial assessing the efficacy of topical lidocaine in extended flexible endoscopic nasal examinations.
    Bonaparte JP; Javidnia H; Kilty S
    Clin Otolaryngol; 2011 Dec; 36(6):550-7. PubMed ID: 22017968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An examination of the double-blind design in drug research with hyperactive children.
    Dalby JT; Kapelus GJ; Swanson JM; Kinsbourne M; Roberts W
    Prog Neuropsychopharmacol; 1978; 2(1):123-7. PubMed ID: 364511
    [No Abstract]   [Full Text] [Related]  

  • 16. Orexin Receptor Antagonism in Painful Diabetic Neuropathy: A Phase 2 Trial With Filorexant.
    Joseph Herring W; Ge JY; Jackson S; Assaid C; Connor KM; Michelson D
    Clin J Pain; 2018 Jan; 34(1):37-43. PubMed ID: 28448426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose conversion between tapentadol immediate and extended release for low back pain.
    Etropolski MS; Okamoto A; Shapiro DY; Rauschkolb C
    Pain Physician; 2010; 13(1):61-70. PubMed ID: 20119464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
    Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter, double-blind study of intravenous milrinone for patients with acute heart failure in Japan. Japan Intravenous Milrinone Investigators.
    Seino Y; Momomura S; Takano T; Hayakawa H; Katoh K
    Crit Care Med; 1996 Sep; 24(9):1490-7. PubMed ID: 8797620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How sound is the double-blind design for evaluating psychotropic drugs?
    Fisher S; Greenberg RP
    J Nerv Ment Dis; 1993 Jun; 181(6):345-50. PubMed ID: 8501455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.